Unable to load price data. Sorry.

¯\_(ツ)_/¯

Hospira, Inc. (NYSE:HSP)

CAPS Rating: No stars

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NYSE:HSP will perform against the market?

Add Stock to CAPS Watchlist

All Players

121 Outperform
30 Underperform
 

All-Star Players

23 Outperform
9 Underperform
 

Wall Street

4 Outperform
3 Underperform
 

Top NYSE:HSP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

traderpat9 (74.21)
Submitted December 31, 2008

HOSPIRA-AN ABBOTT SPINOFF/GOING TO CONTINUE TO GROW DURING GOOD TIMES OR BAD

gailwood (99.31)
Submitted August 24, 2006

Overvalued.

Recent Community Commentary

Read the most recent pitches from players about HSP.

Recs

0
Member Avatar TMTAirborne (87.76) Submitted: 8/4/2015 7:29:44 PM : Underperform Start Price: $89.60 NYSE:HSP Score: +50.38

--FDA Warns Against Use of Hospira Infusion Pumps (August 1 & 3, 2015) The US Food and Drug Administration (FDA) is urging hospitals to stop using certain drug infusion pumps from Hospira. The devices could be accessed by unauthorized users through a hospital's network. The FTP and telnet ports on the devices are open and Port 8443 has a default login password. Once accessed, the pumps could be manipulated to alter drug dosages. One of the affected devices, the Hospira Simbiq Infusion Pump, has been discontinued, but is still in use at some medical facilities.
Other affected devices include the Plum A+ Infusion System v.13.4 and earlier, and the Plum A+ Infusion System v. 13.6 and earlier. Hospira plans to issue updates.
http://www.bbc.com/news/technology-33759428

Plus I find it overvalued, PE and sales.

Recs

0
Member Avatar lejaha (< 20) Submitted: 5/19/2014 5:08:02 PM : Outperform Start Price: $48.00 NYSE:HSP Score: +19.20

This stock will outperform. They will continue to produce results similar the first quarter for the next few quarters.

Recs

0
Member Avatar browndovecapital (50.39) Submitted: 1/7/2012 9:43:16 PM : Outperform Start Price: $30.36 NYSE:HSP Score: +48.39

dddd

Leaderboard

Find the members with the highest scoring picks in HSP.

Score Leader

introscop

introscop (88.42) Score: +150.49

The Score Leader is the player with the highest score across all their picks in HSP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
introscop 88.42 6/24/2010 Underperform 5Y $57.19 +57.28% +194.78% +137.50 0 Comment
OPTIMISTMAN < 20 5/28/2010 Underperform 5Y $52.16 +72.45% +186.79% +114.34 0 Comment
FrontandCenter < 20 8/6/2010 Underperform 1Y $50.75 +77.24% +185.62% +108.38 0 Comment
ModernDayWarrior 32.82 10/29/2009 Underperform 5Y $45.88 +96.05% +201.64% +105.59 0 Comment
Shizzolator 97.88 12/3/2009 Underperform 5Y $48.61 +85.04% +184.45% +99.40 0 Comment
VolatilityRocks < 20 9/29/2009 Underperform 5Y $44.72 +101.14% +197.91% +96.77 0 Comment
TrackCarter 25.07 9/21/2009 Underperform 3M $42.94 +109.48% +199.65% +90.17 0 Comment
CNBL 24.59 4/5/2013 Outperform NS $30.54 +194.53% +105.17% +89.36 0 Comment
mrsulli 35.38 5/2/2013 Outperform 3M $31.64 +184.29% +98.75% +85.54 0 Comment
diverep < 20 6/12/2009 Underperform 3Y $35.11 +156.19% +239.59% +83.39 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for HSP.